Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$2.1 - $3.36 $183,934 - $294,295
-87,588 Reduced 98.2%
1,610 $3,000
Q1 2023

Apr 27, 2023

BUY
$2.13 - $3.6 $57,380 - $96,980
26,939 Added 43.27%
89,198 $227,000
Q4 2022

Feb 02, 2023

SELL
$2.05 - $3.47 $59,665 - $100,994
-29,105 Reduced 31.86%
62,259 $156,000
Q3 2022

Nov 04, 2022

BUY
$0.63 - $5.47 $36,369 - $315,777
57,729 Added 171.63%
91,364 $264,000
Q2 2022

Aug 03, 2022

BUY
$4.27 - $8.26 $66,970 - $129,549
15,684 Added 87.37%
33,635 $152,000
Q1 2022

May 02, 2022

BUY
$7.07 - $11.62 $118,698 - $195,088
16,789 Added 1444.84%
17,951 $143,000
Q4 2021

Feb 23, 2022

BUY
$10.49 - $14.28 $12,189 - $16,593
1,162 New
1,162 $13,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.